These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 25018134
21. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients. Kim YK, Lee KW, Cho SY, Han SS, Kim SH, Kim SK, Park SJ. Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911 [Abstract] [Full Text] [Related]
22. FDG-PET/CT of Vulvar Adenocarcinoma With Diffuse Metastases. Patel D, Anderson TM, Lu Y. Clin Nucl Med; 2016 Sep; 41(9):710-1. PubMed ID: 27187733 [Abstract] [Full Text] [Related]
23. Cerebellar hypermetabolism on ¹⁸F-FDG PET/CT with normal MRI in a case of paraneoplastic cerebellar degeneration with negative antibodies. Sharma P, Mazumdar B, Chatterjee P. Rev Esp Med Nucl Imagen Mol; 2015 Sep; 34(1):79-80. PubMed ID: 25001850 [No Abstract] [Full Text] [Related]
24. Intramedullary metastasis detected with 18F FDG-PET/CT. Sari O, Kaya B, Kara Gedik G, Ozcan Kara P, Varoglu E. Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):299-300. PubMed ID: 23067538 [No Abstract] [Full Text] [Related]
25. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography. Ak I, Sivrikoz MC, Entok E, Vardareli E. Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657 [Abstract] [Full Text] [Related]
26. Early Detection of Bone Metastasis in Small Cell Neuroendocrine Carcinoma of the Cervix by 68Ga-DOTATATE PET/CT Imaging. Damian A, Lago G, Rossi S, Alonso O, Engler H. Clin Nucl Med; 2017 Mar; 42(3):216-217. PubMed ID: 28005640 [Abstract] [Full Text] [Related]
27. Detection of occult bone metastases of lung cancer with fluorine-18 fluorodeoxyglucose positron emission tomography. Foo SS, Ramdave S, Berlangieri SU, Scott AM. Australas Radiol; 2004 Jun; 48(2):214-6. PubMed ID: 15230758 [Abstract] [Full Text] [Related]
28. The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study. Groheux D, Giacchetti S, Espié M, Vercellino L, Hamy AS, Delord M, Berenger N, Toubert ME, Misset JL, Hindié E. J Nucl Med; 2011 Oct; 52(10):1526-34. PubMed ID: 21880576 [Abstract] [Full Text] [Related]
29. [Evaluation of bone scintigraphy and (18)F-FDG PET/CT in bone metastases of lung cancer patients]. Portilla-Quattrociocchi H, Banzo I, Martínez-Rodríguez I, Quirce R, Jiménez-Bonilla J, de Arcocha Torres M, Medina-Quiroz P, del Castillo R, Rubio-Vassallo A, Carril JM. Rev Esp Med Nucl; 2011 Oct; 30(1):2-7. PubMed ID: 21208693 [Abstract] [Full Text] [Related]
30. Variable patterns of positron emission tomography in the assessment of patients with extramammary Paget's disease. Cho SB, Yun M, Lee MG, Chung KY. J Am Acad Dermatol; 2005 Feb; 52(2):353-5. PubMed ID: 15692486 [Abstract] [Full Text] [Related]
31. Multiple distant muscular metastases from non-small cell lung carcinoma evidenced by 18F-FDG PET/CT. Caobelli F, Pizzocaro C, Guerra UP. Rev Esp Med Nucl Imagen Mol; 2013 Feb; 32(5):338-9. PubMed ID: 23809515 [No Abstract] [Full Text] [Related]
32. [Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer]. Fuster D, Lafuente S, Setoain X, Navales I, Perissinotti A, Pavia J, Paredes P, Lomeña F, Pons F. Rev Esp Med Nucl Imagen Mol; 2012 Feb; 31(3):111-6. PubMed ID: 22154291 [Abstract] [Full Text] [Related]
33. Primary Neuroendocrine Carcinoma of the Kidney on FDG PET/CT. Shi X, Li F, Luo Y, Huo L. Clin Nucl Med; 2016 Sep; 41(9):737-9. PubMed ID: 27504808 [Abstract] [Full Text] [Related]
34. Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases. Ozcan Kara P, Kara T, Kara Gedik G, Sari O, Sahin O. Rev Esp Med Nucl; 2011 Sep; 30(2):94-6. PubMed ID: 21342722 [Abstract] [Full Text] [Related]
35. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging. Mittal BR, Manohar K, Kashyap R, Bhattacharya A, Singh B, Singh G. Hell J Nucl Med; 2011 Sep; 14(2):135-9. PubMed ID: 21761015 [Abstract] [Full Text] [Related]
36. Concomitant cutaneous squamous cell carcinoma and chronic lymphocytic leukemia in a patient: The utility of 18 F-FDG PET/CT in differentiation of nodal metastasis. Ozturk K, Ustun C, Khaja S, Li F, Rischall M, Cayci Z. Am J Hematol; 2018 Aug; 93(4):597-598. PubMed ID: 29341235 [No Abstract] [Full Text] [Related]
37. Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma. Périé S, Hugentobler A, Susini B, Balogova S, Grahek D, Kerrou K, Montravers F, Chater PE, St Guily JL, Talbot JN. Otolaryngol Head Neck Surg; 2007 Oct; 137(4):647-53. PubMed ID: 17903585 [Abstract] [Full Text] [Related]
38. Clinical impact of (18)F-FDG PET in management of patients with renal cell carcinoma. Rodríguez Martínez de Llano S, Jiménez-Vicioso A, Mahmood S, Carreras-Delgado JL. Rev Esp Med Nucl; 2010 Oct; 29(1):12-9. PubMed ID: 20022140 [Abstract] [Full Text] [Related]
39. A rare case of clear cell carcinoma of the breast evaluated by (18)F-FDG PET/CT. Treglia G, Perriard U, Ceriani L, Giovanella L. Rev Esp Med Nucl Imagen Mol; 2015 Oct; 34(4):264-5. PubMed ID: 25573809 [No Abstract] [Full Text] [Related]
40. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. Chung JK, So Y, Lee JS, Choi CW, Lim SM, Lee DS, Hong SW, Youn YK, Lee MC, Cho BY. J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]